Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian

Blood (2024) 144 (Supplement 1): 4391.

https://doi.org/10.1182/blood-2024-198485

Published: 2024

Journal Articles

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2024) 144 (Supplement 1): 2171.

https://doi.org/10.1182/blood-2024-212040

Published: 2024

Journal Articles

Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age

Hengwei Wu, Zhiyang Yuan, Xiang Xu, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, Zhongzheng Zheng, He Huang, Yanmin Zhao

Blood (2023) 142 (Supplement 1): 366.

https://doi.org/10.1182/blood-2023-184465

Published: 2023

Journal Articles

Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral Blood

Xiangjun Zeng, Jimei Ge, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao

Blood (2023) 142 (Supplement 1): 4890.

https://doi.org/10.1182/blood-2023-186179

Published: 2023

Journal Articles

Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Luxin Yang, Xiaoyu Lai, Ting Yang, Ying Lu, Lizhen Liu, Jimin Shi, Yanmin Zhao, Yibo Wu, Yi Chen, Jian Yu, Haowen Xiao, Guifang Ouyang, Jinhua Ren, Junjie Cao, Yongxian Hu, Yamin Tan, Zhen Cai, He Huang, Yi Luo

Blood (2022) 140 (Supplement 1): 7676–7677.

https://doi.org/10.1182/blood-2022-166759

Published: 2022

Journal Articles

Comparison of Prophylactic and Preemptive Donor Lymphocyte Infusion in Patients with Very High Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Luxin Yang, Yi Luo, He Huang, Yamin Tan, Jimin Shi, Yanmin Zhao, Jian Yu, Xiaoyu Lai

Blood (2021) 138 (Supplement 1): 3860.

https://doi.org/10.1182/blood-2021-152578

Published: 2021

Journal Articles

Effect of Donor Characteristics on T Cell Replete Haploidentical Stem Cell Transplantation: Over the Last 10 Years at a Single Institution

Yi Luo, Yibo Wu, Jimin Shi, Yamin Tan, Jian Yu, Yanmin Zhao, Xiaoyu Lai, Lizhen Liu, He Huang

Blood (2021) 138 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2021-152641

Published: 2021

Journal Articles

Salvage Therapy with Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem Cell Transplantation

He Huang, MD PhD, Yanmin Zhao, MD, Guifang Ouyang, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Jian Yu, MD, Huarui Fu, MD, Xiaoyu Lai, MD, Lizhen Liu, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-141546

Published: 2020

Journal Articles

Ruxolitinib for Steroid-Refractory cGvHD: A Significant Response in Heavily Pretreated Patients after Haploidentical-SCT

Hengwei Wu, MD, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Mingming Zhang, MD, Xiaoyu Lai, MD, Jian Yu, MD, Lizhen Liu, MD, Huarui Fu, MD, He Huang, MD PhD, Yanmin Zhao, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141561

Published: 2020

Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang

Blood (2019) 134 (Supplement_1): 2668.

https://doi.org/10.1182/blood-2019-127594

Published: 2019

Journal Articles

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Tingting Yang, Xueping Luo, MD, Qing Yang, MD, Hongchao Chen, Yi Luo, MD, Yanmin Zhao, MD, Xiaoyu Lai, MD, Jian Yu, MD, Yamin Tan, MD, Guoqing Wei, MD, He Huang, Jimin Shi, MD

Blood (2019) 134 (Supplement_1): 5606.

https://doi.org/10.1182/blood-2019-127599

Published: 2019

Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4561.

https://doi.org/10.1182/blood-2018-99-118649

Published: 2018

Journal Articles

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Yanmin Zhao, MD, Apeng Yang, MD, Jimin Shi, MD, Yi Luo, MD, Xiaoyu Lai, PhD, Yamin Tan, MD, Jian Yu, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 3427.

https://doi.org/10.1182/blood-2018-99-119027

Published: 2018

Journal Articles

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Lixia Sheng, MD, He Huang, MD PhD, Yamin Tan, Yi Luo, Yongxian Hu, Huarui Fu, Jimin Shi

Blood (2016) 128 (22): 5793.

https://doi.org/10.1182/blood.V128.22.5793.5793

Published: 2016

Journal Articles

Who Is the Better Donor for Young Hematopoietic Transplant Recipients without Siblings: An Older-Aged Haploidentical Parental Donor or a Young Unrelated Donor?

Mingming Zhang, Yi Luo, Yamin Tan, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Zhen Cai, MD PhD, He Huang, MD PhD

Blood (2016) 128 (22): 2290.

https://doi.org/10.1182/blood.V128.22.2290.2290

Published: 2016

Journal Articles

Iron Metabolism before Allo-HSCT in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Jimin Shi, Xuying Pei, Yi Luo, Yamin Tan, Yanmin Zhao, Jingsong He, Weiyan Zheng, Xiaoyu Lai, Gaofeng Zheng, Jie Zhang, Maofang Lin, Zhen Cai, He Huang, MD PhD

Blood (2016) 128 (22): 2461.

https://doi.org/10.1182/blood.V128.22.2461.2461

Published: 2016

Journal Articles

Matched Sibling Versus Haploidentical Hematopoietic Transplant for Adult Patients with Acute Lymphoblastic Leukemia

Mingming Zhang, Yi Luo, Yamin Tan, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Zhen Cai, MD PhD, He Huang, MD PhD

Blood (2016) 128 (22): 2295.

https://doi.org/10.1182/blood.V128.22.2295.2295

Published: 2016

Journal Articles

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

Yi Luo, Yamin Tan, Yongxian Hu, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Yuanyuan Zhu, Jian Yu, Jiasheng Wang, He Huang, MD PhD

Blood (2016) 128 (22): 3439.

https://doi.org/10.1182/blood.V128.22.3439.3439

Published: 2016

Journal Articles

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Yamin Tan, Haowen Xiao, Jianping Lan, Yi Luo, Jimin Shi, Jingsong He, PhD, Xiaoyu Lai, Weiyan Zheng, Zhen Cai, He Huang, MD PhD

Blood (2015) 126 (23): 3130.

https://doi.org/10.1182/blood.V126.23.3130.3130

Published: 2015

Journal Articles

Comparison of Allogeneic Hematopoietic Stem Cell Transplant from HLA-Matched Related Donors and from Unrelated Donors for Intermediate- to High-Risk Adult Acute Myeloid Leukemia in Remission

Mingming Zhang, PhD, Yi Luo, Xiaoyu Lai, Shoucong Chen, Yamin Tan, Weiyan Zheng, Jimin Shi, Zhen Cai, He Huang, MD PhD

Blood (2014) 124 (21): 5946.

https://doi.org/10.1182/blood.V124.21.5946.5946

Published: 2014

NARROW

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age

Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral Blood

Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Comparison of Prophylactic and Preemptive Donor Lymphocyte Infusion in Patients with Very High Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Effect of Donor Characteristics on T Cell Replete Haploidentical Stem Cell Transplantation: Over the Last 10 Years at a Single Institution

Salvage Therapy with Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem Cell Transplantation

Ruxolitinib for Steroid-Refractory cGvHD: A Significant Response in Heavily Pretreated Patients after Haploidentical-SCT

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Who Is the Better Donor for Young Hematopoietic Transplant Recipients without Siblings: An Older-Aged Haploidentical Parental Donor or a Young Unrelated Donor?

Iron Metabolism before Allo-HSCT in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Matched Sibling Versus Haploidentical Hematopoietic Transplant for Adult Patients with Acute Lymphoblastic Leukemia

Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk Patients

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Comparison of Allogeneic Hematopoietic Stem Cell Transplant from HLA-Matched Related Donors and from Unrelated Donors for Intermediate- to High-Risk Adult Acute Myeloid Leukemia in Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only